- Copy top eToro investors automatically with CopyTrader
- Trade stocks, options, ETFs and crypto in one app
- Use a demo account to practice before investing
- See how top investors build their portfolios
In only a few short years, cannabis has emerged as one of the next big market disruptors. Today, as billions of dollars pour into the sector, investors are keen to take part in the anticipated marijuana boom. But before you add marijuana stocks to your portfolio, consider how the unique risks associated with pot stocks may impact profits.
According to VettaFi, there are at least 11 marijuana ETFs listed in the US. Some examples include:
Cannabis refers to plants Cannabis sativa, Cannabis indica and Cannabis ruderalis. This plant can be processed for a variety of purposes, from topical oils and food products to building materials — but it’s popularly grown and consumed for its psychoactive properties.
Cannabis legalization is a divisive subject and the laws that govern its consumption vary by state. Some states, like Washington, Vermont and California, have legalized both recreational and medical marijuana consumption. Others, like Utah, Florida and Pennsylvania, only permit marijuana consumption for medical purposes. In at least 10 other states and under federal law, cannabis consumption is not permitted in any capacity.
Some in Congress are pushing to lift the federal prohibition during the current term, which would be a watershed moment for the industry.
Cannabis stocks are shares of any company that grows, harvests, sells, manufactures or distributes cannabis, including hemp.
Unlike marijuana, hemp is not classified as a narcotic. While hemp and marijuana both come from the cannabis plant, hemp has a lower component of the psychoactive THC — typically less than 0.3% — which means it has no psychoactive effects.
Typically, hemp is used in food products, building materials and textiles. Marijuana, on the other hand, is primarily used for medicinal and recreational purposes.
Despite its lack of legality in numerous states, cannabis is a popular product. And state-level government is becoming more open to its use.
Medical marijuana was first legalized in California in 1996. And in 2012, Colorado and Washington became the first states to legalize the plant’s recreational use. Today, medical marijuana use is legal in 41 US states, with 24 of them also allowing adult use of recreational cannabis.(1)
As more states become accepting of medical and recreational marijuana use, the cannabis market grows. And as the cannabis market grows, so do sales, profits and company valuations.
The shift in attitude towards cannabis isn’t limited to the US. In 2018, Canada legalized recreational marijuana use across the country.(2) And other international governments are reassessing their cannabis laws too, potentially paving the way for an explosion of new businesses.
Statista reports that the global cannabis sector is expected to reach $79.50 billion in 2026 and $114.35 billion by 2031. The cannabis market is one poised for growth — and for investors, growth means profit.
Positive growth projections aside, cannabis may not be a practical addition to your portfolio. And that’s because this sector is riddled with risks — many of which stem from the legality issues that surround the product.
As laws that surround the legalization of recreational marijuana continue to shift, investors must be wary about how high tax rates could impact the market. Tax rates have the potential to cripple cannabis providers in states that allow recreational marijuana because of how high consumers are taxed.
For example, in California consumers must pay a 15% excise tax on each purchase, which is on top of state sales tax and any local taxes that cities and counties may choose to impose.(3) With high taxes, people may choose to purchase their product from unregulated providers.
Financing for cannabis companies is also a concern, as cannabis companies are seen as high-risk merchants in the eyes of many financial institutions. As a result, many of these banks aren’t willing to provide essential banking services and funding must be found elsewhere. One way cannabis companies can raise funds is to issue common stock, but this dilutes the holdings of existing investors.
Overall, the cannabis market seems to be gaining traction. And for investors that can tolerate risk, this is an exciting prospect. But ultimately, the variables that factor into the profitability of this market are constantly in flux — and this sort of instability can lead to price volatility.
The global cannabis market as a whole is expected to grow and it may gain significant traction in the U.S., where its legality remains contended at the federal level. Again, the market value of the cannabis industry in the U.S. is projected to climb to $51.3 billion in 2023 and nearly $102.9 billion by 2028, according to some estimates.
Moreover, U.S. states continue to relax laws around its usage. Since 2020, the following states have legalized marijuana for recreational use:(4)
The MORE Act, which would decriminalize marijuana at the federal level, passed the House in December 2020, but the bill did not advance to the Senate.(5). In September 2023, House Democrats reintroduced the MORE Act once again, though its future remains foggy.(6) So it’s important to carefully analyze cannabis stocks to find where the potential long-term winners may be.
Check out Finder's picks for the best brokerage accounts
Compare top brokerage accounts and apps to help you maximize your investment.
While smoking weed is perhaps the most well-known use of cannabis, there are many types of businesses that are positioned to benefit from the growing sector. As more cannabis products are given the green light, we’ll see the market continue to expand. The legalization of many of these products is new and in some cases, still underway:
The legal cannabis sector is positioned to grow in the coming years and there are a number of ways to invest. But keep in mind that past performance is not a guarantee of profit and all investments come with inherent risks.
Explore your other investment options before you buy.
Not every broker’s free Level 2 data offer is truly free. Here’s exactly what Moomoo, Webull, Fidelity, Schwab and others require in 2026.
An in-depth, fact-checked look at Moomoo’s fees, features, safety and limitations — everything you need before opening an account.
Compare 6 eToro alternatives — Robinhood, Public, Webull, Fidelity, SoFi and Moomoo — for the IRAs, mutual funds and professional-grade tools eToro doesn’t offer.
Moomoo pays up to $600 to switch, but Fidelity charges nothing to leave. See how these two very different brokers compare on fees, IRAs, crypto access and safety in 2026.
SoFi, Robinhood, Tastytrade, Webull, Interactive Brokers, E*TRADE, eToro and others top our list for the best options trading platforms.
Our top 10 beginner-friendly stocks and ETFs, and why we picked them — plus 7 more.
Cash sweep accounts let you earn interest on your uninvested cash. Learn how they work and how to choose the best one here.
Discover the best robo-advisors of 2026. Compare fees, account minimums and features from top platforms that automate investing for beginners and pros.
We’ve rounded up stats on some of the most popular graphene stocks, along with information on how they compare and how to invest.
We’ve rounded up stats on some of the most popular oil stocks, along with information on how they compare and how to invest.